InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,297.10
(
-0.21%
)
US TECH 100
18,078.00
(
-0.21%
)
Dow Jones
39,869.38
(
-0.10%
)
Brent Oil
83.22
(
0.01%
)
Bitcoin
65,396.00
(
0.24%
)
Post# of 104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

tomsylver

Send PM Follow Ignore
Followers 2
Posts 514
Boards Moderated 0
Alias Born 06/15/2007

tomsylver

Re: None

Friday, 11/07/2014 2:34:18 AM

Friday, November 07, 2014 2:34:18 AM

Post# of 104
Dr Bernardo Rapoport speaks to ecancertv

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant

Published on Nov 6, 2014
Visit http://www.ecancer.org for more.

Dr Bernardo Rapoport (The Medical Oncology Centre, Johannesburg, South Africa) speaks to ecancertv at ESMO2014 about the results of his phase III trial, examining the use of rolapitant for the prevention of chemotherapy-induced nausea and vomiting.

ecancer's filming at ESMO has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up